Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 182

Similar articles for PubMed (Select 19818218)

1.

Vitamin D endocrine system and psoriasis vulgaris--review of the literature.

Rucević I, Barisić-Drusko V, Glavas-Obrovac L, Stefanić M.

Acta Dermatovenerol Croat. 2009;17(3):187-92. Review.

PMID:
19818218
2.

The vitamin D hormone and its nuclear receptor: molecular actions and disease states.

Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK.

J Endocrinol. 1997 Sep;154 Suppl:S57-73. Review.

3.

Vitamin D and systemic cancer: is this relevant to malignant melanoma?

Osborne JE, Hutchinson PE.

Br J Dermatol. 2002 Aug;147(2):197-213. Review.

PMID:
12174089
4.

Vitamin D receptor gene polymorphisms in relation to Vitamin D related disease states.

Uitterlinden AG, Fang Y, van Meurs JB, van Leeuwen H, Pols HA.

J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):187-93.

PMID:
15225770
5.

Polymorphism of the vitamin D(3) receptor in patients with psoriasis.

Okita H, Ohtsuka T, Yamakage A, Yamazaki S.

Arch Dermatol Res. 2002 Jul;294(4):159-62. Epub 2002 May 28.

PMID:
12111344
6.

Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.

Boehm MF, Fitzgerald P, Zou A, Elgort MG, Bischoff ED, Mere L, Mais DE, Bissonnette RP, Heyman RA, Nadzan AM, Reichman M, Allegretto EA.

Chem Biol. 1999 May;6(5):265-75.

7.

1alpha,25-dihydroxyvitamin D3 inducible transcription factor and its role in the vitamin D action.

Nezbedova P, Brtko J.

Endocr Regul. 2004 Mar;38(1):29-38. Review.

PMID:
15147236
8.

Polymorphisms of vitamin D receptor gene in Japanese patients with psoriasis vulgaris.

Saeki H, Asano N, Tsunemi Y, Takekoshi T, Kishimoto M, Mitsui H, Tada Y, Torii H, Komine M, Asahina A, Tamaki K.

J Dermatol Sci. 2002 Nov;30(2):167-71.

PMID:
12413773
9.

Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma.

Hutchinson PE, Osborne JE, Lear JT, Smith AG, Bowers PW, Morris PN, Jones PW, York C, Strange RC, Fryer AA.

Clin Cancer Res. 2000 Feb;6(2):498-504.

10.

Polymorphisms of vitamin D receptor gene in the population of eastern Croatia with psoriasis vulgaris and diabetes mellitus.

Polić MV, Rucević I, Barisić-Drusko V, Miskulin M, Glavas-Obrovac L, Stefanić M, Karner I, Lipozencić J, Bacun T, Mihaljević I.

Coll Antropol. 2012 Jun;36(2):451-7.

PMID:
22856230
11.

Vitamin D receptor ApaI, TaqI, BsmI, and FokI polymorphisms and psoriasis susceptibility: a meta-analysis.

Lee YH, Choi SJ, Ji JD, Song GG.

Mol Biol Rep. 2012 Jun;39(6):6471-8. doi: 10.1007/s11033-012-1466-6.

PMID:
22290287
13.

The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis.

Smolders J, Peelen E, Thewissen M, Menheere P, Tervaert JW, Hupperts R, Damoiseaux J.

Autoimmun Rev. 2009 Jun;8(7):621-6. doi: 10.1016/j.autrev.2009.02.009. Epub 2009 Feb 11. Review.

PMID:
19393206
14.

Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases.

Adorini L.

Int Immunopharmacol. 2002 Jun;2(7):1017-28. Review.

PMID:
12188026
15.

Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3.

Christakos S, Raval-Pandya M, Wernyj RP, Yang W.

Biochem J. 1996 Jun 1;316 ( Pt 2):361-71. Review. Erratum in: Biochem J 1996 Sep 15;318(Pt 3):1079.

16.

Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1, 25-dihydroxyvitamin D3.

Colin EM, Weel AE, Uitterlinden AG, Buurman CJ, Birkenhäger JC, Pols HA, van Leeuwen JP.

Clin Endocrinol (Oxf). 2000 Feb;52(2):211-6.

PMID:
10671949
17.

VDR FokI polymorphism is associated with a reduced T-helper cell population under vitamin D stimulation in type 1 diabetes patients.

Morán-Auth Y, Penna-Martinez M, Badenhoop K.

J Steroid Biochem Mol Biol. 2015 Apr;148:184-6. doi: 10.1016/j.jsbmb.2015.01.003. Epub 2015 Jan 7.

PMID:
25576905
18.

The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature.

Köstner K, Denzer N, Müller CS, Klein R, Tilgen W, Reichrath J.

Anticancer Res. 2009 Sep;29(9):3511-36. Review.

19.

Vitamin D receptor as a drug discovery target.

Pinette KV, Yee YK, Amegadzie BY, Nagpal S.

Mini Rev Med Chem. 2003 May;3(3):193-204. Review.

PMID:
12570835
20.

Vitamin D receptor ligands for osteoporosis.

Cheskis BJ, Freedman LP, Nagpal S.

Curr Opin Investig Drugs. 2006 Oct;7(10):906-11. Review.

PMID:
17086935
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk